Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026)
Kiniksa Pharmaceuticals International's Selling, General & Administrative was $63.87 million in Q2 2026, up 36.3% from $46.86 million a year earlier and up 4.4% from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Selling, General & Administrative was $230.9 million through Jun 30, 2026, up 30.2% year-over-year; for FY2025, it was $196.27 million, up 16.8% from FY2024.
- Selling, General & Administrative has now increased for eight consecutive years, with a five-year compound annual growth rate of 34.1% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $168.01 million in FY2024 (+29.8%), $129.43 million in FY2023 (+32.1%), $97.95 million in FY2022 (+14.0%) and $85.95 million in FY2021 (+89.6%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2017.
- Compared with a year earlier, Selling, General & Administrative has increased for 33 straight quarters, with growth averaging 23.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 5.8% (Q3 2025) to 75.9% (Q3 2021).
- Per Business Quant data, KNSA's Selling, General & Administrative in the three quarters before Q2 2026 was $61.15 million (Q1 2026), $56.78 million (Q4 2025) and $49.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 63.87 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.87 Mn |
| Mar 31, 2026 | 61.15 Mn |
| Dec 31, 2025 | 56.78 Mn |
| Sep 30, 2025 | 49.10 Mn |
| Jun 30, 2025 | 46.86 Mn |
| Mar 31, 2025 | 43.53 Mn |
| Dec 31, 2024 | 40.54 Mn |
| Sep 30, 2024 | 46.40 Mn |
| Jun 30, 2024 | 42.40 Mn |
| Mar 31, 2024 | 38.68 Mn |
| Dec 31, 2023 | 36.74 Mn |
| Sep 30, 2023 | 34.47 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 29.05 Mn |
| Dec 31, 2022 | 27.22 Mn |
| Sep 30, 2022 | 24.68 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 22.22 Mn |
| Dec 31, 2021 | 22.74 Mn |
| Sep 30, 2021 | 20.76 Mn |
Kiniksa Pharmaceuticals International Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();